Comparative pharmacoeconomic evaluation of the use of specific drug treatment for endometriosis

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (14)

• A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
• Clinical practice. Endometriosis via openalex
• Dienogest in long-term treatment of endometriosis via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
• Differences in characteristics among 1,000 women with endometriosis based on extent of disease via openalex
• Endometriosis and infertility: epidemiology and evidence-based treatments via openalex
• Endometriosis-associated infertility via openalex
• Endometriosis: cost estimates and methodological perspective via openalex
• Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases via openalex
• Progestagens and anti-progestagens for pain associated with endometriosis via openalex
• W2093629698 via openalex
• W2101417341 via openalex
• W2021687464 via openalex

Cited by (1)

• Correction of immune disorders and changes in the protein/lipid spectrum of circulating erythrocyte membranes in adenomiosis 2018

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00